Lv1
30 积分 2024-02-20 加入
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
1个月前
已完结
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
1个月前
已完结
High-throughput screening for class I peptide MHC binding via yeast surface display
2个月前
已完结
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy
3个月前
已完结
An autoimmune stem-like CD8 T cell population drives type 1 diabetes
5个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
7个月前
已完结
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
7个月前
已完结
Pancreatic islet-specific engineered T regs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models
7个月前
已完结
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches
7个月前
已完结
Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence
7个月前
已完结
皖公网安备34019202002308
